Patent Grant
11690559
This document relates generally to medical devices and more particularly to a system that monitors a patient for predicting, detecting, and/or treating respiratory distress.
Obstructive lung diseases, including chronic obstructive pulmonary disease (COPD) and asthma, are characterized by narrowing airways that can make fully expelling air from the lungs difficult. COPD and asthma patients can experience a significant decline in health (e.g., acute COPD exacerbations and asthma attacks), to extents that require hospitalization. Despite advances in therapeutics, the prevalence of COPD and asthma continues to grow.
COPD currently affects nearly 13 million people in the United States and is the third leading cause of death in the country. The overwhelming primary cause of COPD is inhalation of cigarette smoke, responsible for over 90% of COPD cases. The economic and social burden of the disease is substantial and is increasing. The annual economic burden is currently estimated to be around $32 billion in the United States alone. Conditions associated with COPD include chronic bronchitis and emphysema. Chronic bronchitis is characterized by chronic cough with sputum production. Airway inflammation, mucus hypersecretion, airway hyper-responsiveness, and eventual fibrosis of the airway walls result in significant airflow and gas exchange limitations. Emphysema is characterized by destruction of the lung parenchyma, which leads to a loss of elastic recoil and tethering that maintains airway patency. Because bronchioles are not supported by cartilage like the larger airways are, they have little intrinsic support and therefore are susceptible to collapse when destruction of tethering occurs, particularly during exhalation.
Asthma is similar to chronic bronchitis, though its underlying cause is often an inherent defect of airway smooth muscle or the inflammatory milieu, which makes airway smooth muscle hyperreactive. Chronic asthma can have similar airway wall thickening as in chronic bronchitis, leading to a permanent, irreversible airflow obstruction. Asthma impacts over 18 million adults in the United States. Strikingly, there are 1.6 million visits to the emergency rooms resulting from this disease in the United States annually. Asthma COPD overlap syndrome (ACOS) is a condition in which a patient has clinical features of both asthma and COPD. ACOS patients are often among the sickest and most difficult to treat.
The most significant contributor to the economic burden of these diseases is related to healthcare services for asthma attacks and acute exacerbations of COPD (AECOPD), mostly emergency care and inpatient health care. Despite relatively efficacious drugs that treat COPD symptoms (e.g., long-acting muscarinic antagonists, long-acting beta agonists, corticosteroids, and antibiotics), a particular segment of patients known as “frequent exacerbators” often visit the emergency rooms and hospitals with exacerbations and also have a more rapid decline in lung function, poorer quality of life, and greater mortality. Similarly, a group of severe asthmatics are amongst those who visits the emergency rooms most frequently.
Currently, a successful strategy for managing asthma and COPD is the action plan that follows a “traffic light model” to monitor patient conditions and respond to changes. The traffic light model uses the analogy of traffic lights to illustrate the seriousness of symptoms (with green, yellow, and red zones) and the action a patient must take in each zone. This technique can be used by patients as well as caretakers to monitor symptoms. However, this approach has its limitations. For example, the patient must be compliant and be able to recognize symptoms.
An example (e.g., “Example 1”) of a system for monitoring and treating respiratory distress in a patient may include signal inputs, a signal processing circuit, and a respiratory distress analyzer. The signal inputs may be configured to receive patient condition signals indicative of autonomic balance of the patient. The signal processing circuit may be configured to process the patient condition signals and to generate patient condition parameters using the processed patient condition signals. The patient condition parameters may be indicative of the autonomic balance of the patient. The respiratory distress analyzer may be configured to determine a state of the respiratory distress using the patient condition parameters. The respiratory distress analyzer may include a parameter analysis circuit, which may be configured to analyze the autonomic balance of the patient and to determine the state of the respiratory distress using an outcome of the analysis.
In Example 2, the subject matter of Example 1 may optionally be configured to further include a therapy device configured to deliver one or more therapies treating the respiratory distress and a control circuit configured to control the delivery of the one or more therapies based on the state of the respiratory distress.
In Example 3, the subject matter of any one or any combination of Examples 1 and 2 may optionally be configured to further include a storage device configured to store the state of the respiratory distress determined over time, and may optionally be configured such that the parameter analysis circuit is configured to produce and analyze a trend of the state of the respiratory distress.
In Example 4, the subject matter of any one or any combination of Examples 1 to 3 may optionally be configured such that the parameter analysis circuit is configured to determine a patient condition metric being a linear or nonlinear combination of the patient condition parameters and to produce one or more respiratory distress indicators indicating the state of the respiratory distress based on the patient condition metric, and the respiratory distress analyzer further includes a notification circuit configured to present the one or more respiratory distress indicators.
In Example 5, the subject matter of Example 4 may optionally be configured such that the parameter analysis circuit is configured to perform at least one of prediction or detection of an exacerbation of the respiratory distress based on the patient condition metric, and the notification circuit is configured to produce an alert notifying a result of the performance of the at least one of prediction or detection of the exacerbation.
In Example 6, the subject matter of Example 5 may optionally be configured such that the signal processing circuit is configured to generate patient condition parameters indicative of one or more physiological markers of asthma, the parameter analysis circuit is configured to perform at least one of prediction or detection of an asthma attack, and the notification circuit is configured to produce an asthma alert notifying at least one of the asthma attack being predicted or the asthma attack being detected.
In Example 7, the subject matter of any one or any combination of Examples 5 and 6 may optionally be configured such that the signal processing circuit is configured to generate patient condition parameters indicative of one or more physiological markers of chronic obstructive pulmonary disease (COPD), the parameter analysis circuit is configured to perform at least one of prediction or detection of an exacerbation of COPD, and the notification circuit is configured to produce a COPD alert notifying at least one of the exacerbation of COPD being predicted or the exacerbation of COPD being detected.
In Example 8, the subject matter of any one or any combination of Examples 1 to 7 may optionally be configured to further include a signal processing controller and a signal processing sensor. The signal processing controller is configured to receive a processing control signal and adjust the processing of the patient condition signals based on the processing control signal. The signal processing sensor is configured to sense a physical state of the patient and to produce the processing control signal based on the physical state.
In Example 9, the subject matter of Example 8 may optionally be configured such that the signal processing sensor includes one or more of an activity sensor configured to sense an activity level of the patient or a sleep sensor configured to sense whether the patient is sleeping.
In Example 10, the subject matter of any one or any combination of Examples 1 to 9 may optionally be configured such that the signal inputs are configured to receive one or more respiratory signals indicative of respiratory cycles including inspiratory and expiratory phases and one or more cardiac signals indicative of cardiac cycles including at least ventricular depolarizations, the signal processing circuit is configured to process the one or more respiratory signals and the one or more cardiac signals and to generate one or more respiration-mediated physiological parameters of the patient condition parameters, and the parameter analysis circuit is configured to determine the state of the respiratory distress based on at least the one or more respiration-mediated physiological parameters.
In Example 11, the subject matter of Example 10 may optionally be configured such that the signal processing circuit is configured to generate one or more respiration sinus arrhythmia (RSA) parameters of the one or more respiration-mediated physiological parameters, the one or more RSA parameters being one or more measures of the RSA, and the parameter analysis circuit is configured to determine the state of the respiratory distress based on at least the one or more RSA parameters.
In Example 12, the subject matter of any one or any combination of Examples 1 to 11 may optionally be configured such that the signal inputs are configured to receive one or more blood pressure signals indicative of blood pressure, one or more cardiac signals indicative of cardiac cycles including at least ventricular depolarizations and one or more physical state signals indicative of a physical state of the patient, the signal processing circuit is configured to process the one or more blood pressure signals, the one or more cardiac signals, and the one or more physical state signals and to generate one or more baroreflex sensitivity (BRS) parameters of the patient condition parameters, the one or more BRS parameters being one or more measures of the BRS, and the parameter analysis circuit is configured to determine the state of the respiratory distress based on at least the one or more BRS parameters.
In Example 13, the subject matter of Example 12 may optionally be configured such that the signal processing circuit is configured to generate detect levels of physical activity or exertion of the patient from the one or more physical state signals and to generate the one or more BRS parameters each for a plurality of levels of the physical activity or exertion.
In Example 14, the subject matter of any one or any combination of Examples 12 and 13 may optionally be configured such that the signal processing circuit is configured to generate detect a type of posture change of the patient from the one or more physical state signals and to stratify the one or more BRS parameters by the detected type of posture change.
In Example 15, the subject matter of any one or any combination of Examples 12 to 14 may optionally be configured such that the signal processing circuit is configured to generate detect one or more of a magnitude or a duration of posture change of the patient from the one or more physical state signals and to stratify the one or more BRS parameters by the detected one or more of the magnitude or the duration of posture change.
An example (e.g., “Example 16”) of a method for monitoring and treating respiratory distress in a patient is also provided. The method may include receiving patient condition signals indicative of autonomic balance of the patient and monitoring the state of the respiratory distress automatically using a respiratory distress monitoring circuit. The monitoring may include processing the patient condition signals, generating patient condition parameters using the processed patient condition signals, the patient condition parameters indicative of the autonomic balance of the patient, analyzing the autonomic balance of the patient using the patient condition parameters, and determining the state of the respiratory distress using an outcome of the analysis.
In Example 17, the subject matter of Example 16 may optionally further include delivering one or more therapies treating the respiratory distress and controlling the delivery of the one or more therapies based on the state of the respiratory distress.
In Example 18, the subject matter of any one or any combination of Examples 16 and 17 may optionally further include determining a patient condition metric being a linear or nonlinear combination of the patient condition parameters, performing at least one of prediction or detection of an exacerbation of the respiratory distress based on the patient condition metric, and producing an alert notifying a result of the performance of the at least one of prediction and detection.
In Example 19, the subject matter of any one or any combination of Examples 16 to 18 may optionally further include sensing a physical state of the patient and adjusting the processing of the patient condition signals based on the sensed physical state.
In Example 20, the subject matter of receiving patient condition signals as found in any one or any combination of Examples 16 to 19 may optionally further include receiving one or more respiratory signals indicative of respiratory cycles including inspiratory and expiratory phases and one or more cardiac signals indicative of cardiac cycles including at least ventricular depolarizations, and the subject matter of generating the patient condition parameters as found in any one or any combination of Examples 16 to 19 may optionally further include generating one or more respiration-mediated physiological parameters of the patient condition parameters.
In Example 21, the subject matter of generating the one or more respiration-mediated physiological parameters as found in claim 20 may optionally further include generating one or more respiration sinus arrhythmia (RSA) parameters being one or more measures of the RSA.
In Example 22, the subject matter of receiving patient condition signals as found in any one or any combination of Examples 16 to 21 may optionally further include receiving one or more blood pressure signals indicative of blood pressure, one or more cardiac signals indicative of cardiac cycles including at least ventricular depolarizations, and one or more physical state signals indicative of a physical state of the patient, and the subject matter of generating the patient condition parameters as found in any one or any combination of Examples 16 to 21 may optionally further include generating one or more baroreflex sensitivity (BRS) parameters being one or more measures of the BRS.
In Example 23, the subject matter of generating the patient condition parameters as found in claim 22 may optionally further include one or more of: detecting levels of physical activity or exertion of the patient from the one or more physical state signals and generating the one or more BRS parameters each for a plurality of levels of the physical activity or exertion, detecting a type of posture change of the patient from the one or more physical state signals and stratifying the one or more BRS parameters by the detected type of posture change, detecting a magnitude or a duration of posture change of the patient from the one or more physical state signals and stratifying the one or more BRS parameters by the detected magnitude of posture change, or detecting a duration of posture change of the patient from the one or more physical state signals and stratifying the one or more BRS parameters by the detected duration of posture change.
This Summary is an overview of some of the teachings of the present application and not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details about the present subject matter are found in the detailed description and appended claims. Other aspects of the disclosure will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which are not to be taken in a limiting sense. The scope of the present disclosure is defined by the appended claims and their legal equivalents.
The drawings illustrate generally, by way of example, various embodiments discussed in the present document. The drawings are for illustrative purposes only and may not be to scale.
In the following detailed description, reference is made to the accompanying drawings which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural, logical and electrical changes may be made without departing from the spirit and scope of the present invention. References to “an”, “one”, or “various” embodiments in this disclosure are not necessarily to the same embodiment, and such references contemplate more than one embodiment. The following detailed description provides examples, and the scope of the present invention is defined by the appended claims and their legal equivalents.
This document discusses, among other things, systems and methods for monitoring respiratory distress, including detection and/or prediction of exacerbations of pulmonary diseases affecting airways, such as asthma and chronic obstructive pulmonary disease (COPD). Exacerbations of such diseases create significant economic burden on the healthcare system. Patients experiencing these episodes tend to deteriorate over time. Thus, there is a need for consistent and accurate means to monitor patient status and detect worsening systems prior to an episode requiring hospitalization.
Studies have shown variable durations of increased signs and/or symptoms leading up to exacerbations in asthma patients. However, there are noticeable trends in signs and/or symptoms on average approximately one week prior to the episode. One study found that patients (at least 16 years old, from 11 countries, structured interviews of 3415 adults) reported a mean time from the first appearance to peak of signs and symptoms of 5.1 days (range: <30 minutes to >2 weeks) and a mean interval from the peak of symptoms to recovery of 6.2 days. Another study found that the mean maximal decrease in the morning PEF was 16% to 20%. This decrease was gradual, from day-10 to day-3, followed by a more rapid decrease. It is believed that fast onset episodes are due to triggers such as allergens and irritants, while slow onset episodes are due to faults in management. Analysis of fatal asthma attacks showed that 80% of them had slow onset.
Similar to asthma patients, COPD patients generally have a slow onset of signs and/or symptoms which has been reported to be approximately 1-2 weeks in duration, with symptoms steadily increased from 2 weeks prior to exacerbation, with a sharp rise during the last week. Respiratory tract infection is one of the most common triggers for COPD exacerbation, accounting for a majority of exacerbations.
There is a need for effective monitoring of patients to provide a reliable indication of their conditions and monitor respiratory distress to (1) warn the patients and provide a window to administer therapy to prevent hospitalizations, and/or (2) to alert patients and appropriate medical personnel of the onset of an exacerbation to get the patient the appropriate medical care. There is a need for reducing occurrence of events such as asthma attacks and acute exacerbations of COPD (AECOPD) for these patients, as such events are the primary contributor to the economic and social burden of respiratory diseases.
Failure to provide the correct type and/or duration of therapy for an asthma attack or acute exacerbation of COPD can prevent recovery, delay recovery, or result in an additional asthma attack or acute exacerbation of COPD soon after the initial disease event. Hence there is a need to monitor treatment of patients during recovery from an asthma attack and acute exacerbation of COPD. In one example, there is a need to monitor patients during hospitalization and emergency room visits for asthma attack and acute exacerbation of COPD to ensure the recovery therapy is effective and to prevent premature discharge. In another example, there is a need to monitor patients during recovery away from a hospital setting (e.g., at-home, or nursing home) to ensure compliance and effectiveness of the recovery therapy. Monitoring during recovery may be different from or the same as monitoring apart from recovery. Monitoring during recovery may include more frequent data gathering, gathering of additional or different parameters, and/or more frequent reporting to a caregiver (e.g., medical professional, or at-home caregiver).
As a patient's signs and/or symptoms worsen preceding an exacerbation, non-invasive devices can be used to capture symptomatic and physiological changes to warn the patient of declining health and/or alert appropriate personnel in the event of an exacerbation episode. Signs associated with airway obstruction such as coughing, wheezing (lung sounds), increased respiration rate, and lung hyperinflation can be captured by monitoring the patient using a system of non-invasive sensors. In addition, measures of autonomic activity can be monitored over time to assess patient condition and send a warning for a likely exacerbation based on signals acquired and/or alert appropriate personnel in the event of an exacerbation so that the patient can promptly receive medical attention.
In one example, the present subject matter provides a system that includes a noninvasive or minimally invasive system for monitoring COPD and asthma patients to provide a reliable indication of their condition and detect (1) worsening signs and/or symptoms, to warn patients and provide a window to administer therapy to prevent hospitalizations, and/or (2) exacerbations, in the event of rapid onset of signs and/or symptoms, to alert appropriate medical personnel of the onset of an exacerbation to get the patient the appropriate medical care. This system can also identify changes in the patient's condition subsequent to therapy to indicate a need for adjustment or termination of the therapy. In various embodiments, the system can include one or more sensors that can indirectly or directly sense symptoms and/or physiological signals indicative of worsening condition and/or onset of an exacerbation. The system can also contain a processing unit to process incoming signals and extract appropriate signal information. The processing unit can execute an algorithm to process the incoming signals along with stored data (e.g., trend data) to assess the patient's condition. In the event of worsening signs and/or symptoms preceding or at the onset of an exacerbation, the system can notify the patient, caregiver, and/or appropriate medical personnel.
A biomarker of respiratory distress, such as respiration sinus arrhythmia (RSA), can be captured invasively or noninvasively through direct or indirect means to provide an indication of the patient's condition and provide a warning when the condition becomes worse. RSA is a short term measure of heart rate variability (HRV), and is a physiological indicator that may have implications for monitoring pulmonary diseases such as asthma and COPD. RSA can be used to assess cardiac autonomic function, and can represent the transfer function from respiration rate to cardiac cycle length (e.g., time intervals between successive R-waves, the R-R intervals). During inspiration, inhibitory signals decrease vagal nerve activity, resulting in increased heart rate and decreased RSA. Conversely, during expiration, increasing vagus nerve activity results in decreased HR and increased RSA.
Asthma and COPD are associated with impairment in the autonomic balance (coordination between the sympathetic and parasympathetic nervous systems) which can be reflected by monitoring HRV and/or RSA. This imbalance, demonstrated in COPD patients, manifests as an elevation in sympathetic activity and a withdrawal of parasympathetic activity. In studies with asthma patients, the imbalance in the autonomic nervous system results from the hyperactivity of the parasympathetic branch causing bronchial constriction. In addition, the dysfunction or hypoactivity of the sympathetic branch has been tied to the severity of asthma. These alterations in autonomic balance can be monitored for individual patients to see when RSA deviates from a baseline value, either increasing or decreasing. Since this measure is based on the respiratory signal, RSA can continuously be evaluated to provide feedback on the patient's condition that does not require the patient to be performing a specific task or at an in-office assessment. Additional respiration mediated signals could be captured as a surrogate to heart rate including blood pressure, blood flow/perfusion, heart sounds, direct neural recordings, and blood gas (O2 and CO2) concentrations.
In one example, the present subject matter provides a system that can monitor respiration-mediated signals in patients with pulmonary diseases that restrict airflow, such as asthma, COPD, chronic bronchitis, and emphysema. Heart rate responses to respiration can be captured through invasive or non-invasive means to monitor the patient's condition. This system can alert the patient or caretaker of worsening conditions and/or the need for intervention. This system can also identify changes in the patient's condition subsequent to therapy to indicate a need for adjustment or termination of the therapy. In various embodiments, the system can include one or more sensors that can directly or indirectly sense a respiratory signal and another physiological signal modulated by respiration. These signals can be processed to extract period of the respiration cycle including inspiration and expiration phases. The corresponding respiratory periods of the cardiac signal can be processed to extract heart rate and inter-beat intervals (the R-R intervals). An algorithm can be executed to calculate respiration-mediated signal indices and provide a measure of the patient's condition.
Arterial baroreflex (also referred to as baroreceptor reflex) is important for hemodynamic stability and cardioprotection, and is a strong prognostic indicator. The carotid and aortic baroreceptors detect changes in pressure, providing negative feedback to the closed-loop system for regulating blood pressure. In a healthy person, when baroreceptor activation increases due to a blood pressure increase, efferent parasympathetic activity increases to lower blood pressure through slowing the heart rate and causing peripheral vasodilation. Baroreflex sensitivity (BRS), defined as the change in inter-beat interval (IBI) in ms/mmHg, provides an indication of the function of this closed-loop system and can be measured from standard heart rate and blood pressure monitoring techniques.
Asthma and COPD are associated with impairment in the autonomic balance which can be reflected by monitoring BRS, either through spontaneous measures or clinical evaluations. This imbalance, as demonstrated in COPD patients, manifests as an elevation in sympathetic activity and a withdrawal of parasympathetic activity resulting in decreased BRS. In studies with asthma patients, the imbalance in the autonomic nervous system results from the hyperactivity of the parasympathetic branch. Treatment has been shown to decrease BRS as the cardiovagal responsiveness decrease and sympathetic activity increases. These alterations in autonomic balance can be monitored for individual patients to see when BRS deviates from a baseline value, either increasing or decreasing. Since this measure is based on the respiratory signal, BRS can continuously be evaluated to provide feedback on the patient's condition that does not require the patient to be performing a specific task or at an in-office assessment.
In the event of an AECOPD or asthma attack, the patient has heightened sympathetic nervous system activity, which causes in increase in blood pressure and heart rate. The increased blood pressure in turn activates baroreceptors which down-regulate sympathetic outflow, restoring homeostasis. This baroreflex can increase or decrease blood pressure. In a healthy person who transitions abruptly from a supine to standing position, pooling of blood in the lower extremities causes an immediate arterial blood pressure reduction, which in turn activates baroreceptors to increase sympathetic outflow causing a blood pressure and heart rate increase, again restoring homeostasis. These are healthy compensatory responses. An attenuated baroreceptor response causes a reduced and delayed heart rate and blood pressure response to a posture change (or any physical activity that typically activate the baroreceptors).
Natural BRS response has variability due to respiration, physical and mental stressors, which is evident in everyday activities. These dynamics can be used as an indicator of baroreceptor function, and can be used to monitor patients with airflow limitations. The dynamic BRS response can be captured using beat-to-beat sensitivity to investigate changes in heart rate and blood pressure for each cardiac contraction. One method for measuring BRS is measuring spontaneous BRS. Spontaneous BRS can be measured through consecutive beats that are characterized by simultaneous increases or decreased in blood pressure and R-R interval. BRS is then calculated as the average of the linear regression slopes detected for each sequence over a given time interval. Examples for measuring this dynamic response include measuring through monitoring respiration and/or physical activity.
Similar to respiratory sinus arrhythmia and diminished HRV, diminished BRS is evident in COPD and asthma patients. The dynamic spontaneous BRS can be captured through analysis of blood pressure and heart rate during a respiratory cycle. This is because there is always spontaneous blood pressure variability (BPV) due to respiration. Respiration induces HRV by mediation of the arterial baroreflex and by direct mechanical modulation of the SA node pacemaker properties. Using inspiration and expiration, consecutive increases or decreases can be captured to calculate BRS for monitoring the patient.
Moment-to-moment regulation of blood pressure through the baroreflex is reduced during exercise in comparison to rest. BRS decreases during exercise because the body's operating point on the curve of heart rate against blood pressure has shifted away from the maximal sensitivity point at the center of the curve (at rest condition). The shift moves the “set point” of blood pressure to a higher level with less sensitivity to changes in blood pressure. This change in baroreflex depends on exercise intensity. As the exercise intensity increases (as the heart rate increases), the response curve changes with the lowest sensitivity at the highest exercise intensity where the subjects maintained a heart rate of 150 beat per minute (bpm). As the exercise intensity increases, the operating point progressively moves away from the center point towards the upper threshold of the curve. Pulmonary disease affecting airways such as asthma and COPD are associated with alterations in autonomic function. This dysfunction can be investigated through physical activity by monitoring the baroreflex. Exercise alone causes a decrease in BRS, and exercise compounded with airway limitation may lead to a more significant reduction in BRS. By coupling activity and BRS monitoring, the baroreflex can be evaluated at a higher operating point (due to exercise) for monitoring the patient's condition and evaluating the need for therapeutic intervention.
In one example, the present subject matter provides a system for ambulatory assessment of baroreceptor response. The patient's baroreceptor response to events such as respiration or activity can be used for monitoring the patient's condition related to pulmonary disease, such as asthma and COPD. Heart rate, blood pressure, respiration, and activity signals can be sensed through invasive or non-invasive means, through direct or indirect measures. This system can alert the patient or caretaker of worsening conditions or the need for intervention. This system can also identify changes in the patient's condition subsequent to therapy to indicate a need for adjustment or termination of the therapy. In various embodiments, this system can include an activity sensor, a respiration sensor, and an additional sensor for measuring baroreceptor response. The system can include a processor to process the signals produced by these sensors to analyze the spontaneous baroreceptor response during respiration as detected by the respiration sensor and/or during physical activity as detected by the activity sensor. The processor can execute an algorithm to calculate baroreceptor response indices to provide a measure of the patient's condition.
Signal inputs 101 can receive patient condition signals indicative of a state of the respiratory distress of the patient. Signal processing circuit 102 can process the patient condition signals and generate patient condition parameters using the processed patient condition signals. The patient condition parameters are indicative of the state of the respiratory distress of the patient. Respiratory distress analyzer 103 can determine the state of the respiratory distress using the patient condition parameters. Respiratory distress analyzer 103 can include parameter inputs 104 and a parameter analysis circuit 105. Parameter inputs 104 can include a physiological marker input 106 to receive one or more physiological marker parameters of the patient condition parameters and an other parameter input 107 to receive one or more other parameters of the patient condition parameters that can be used in the determination of the state of the respiratory distress. The one or more physiological marker parameters represent one of more physiological markers for the respiratory distress and can be one or more quantitative measures of the respiratory distress. Parameter analysis circuit 105 can analyze the patient condition parameters received from signal processing circuit 102 and determine the state of the respiratory distress using an outcome of the analysis.
In one embodiment, the patient condition signals include signals acquired by non-invasive sensors such that respiratory distress monitoring circuit 100 can be used in a non-invasive patient monitoring and/or treatment system. In one embodiment, the patient condition signals include signals indicative of autonomic balance of the patient, and parameter analysis circuit 105 can to analyze the autonomic balance of the patient and determine the state of the respiratory distress based on a state of the autonomic balance. Examples of measures of autonomic balance include RSA and BRS. In one embodiment, parameter analysis circuit 105 can produce a patient condition metric being a linear or nonlinear function of the patient condition parameters and predict an exacerbation of the respiratory distress based on the patient condition metric. Respiratory distress analyzer 103 can produce an alert notifying the prediction of the exacerbation.
Signal input 201 can represent an example of signal input 101 and can receive the patient condition signals indicative of the state of the respiratory distress. The patient condition signals can include one or more signals sensed by one or more sensors and indicative physiological markers of the respiratory distress and one or more other signals that can otherwise be used by respiratory distress analyzer 203 in determining the state of the respiratory distress. Signal processing circuit 202 can represent an example of signal processing circuit 102 and can process the patient condition signals received by signal inputs 201 and can generate patient condition parameters indicative of the state of the respiratory distress. The patient condition parameters can include one or more physiological marker parameters that are indicative of the physiological markers of the respiratory distress and can allow for detection and/or prediction of exacerbation. In various embodiments, a sensor or a combination of sensors can be employed to monitor symptoms and physiological markers indicative of the state of the respiratory distress. Examples of physiological markers of respiratory distress that can be signs for exacerbation include:
In various embodiments, the one or more physiological marker parameters can each indicate and/or be a measure of one or more of these physiological markers. Table 1 includes a more complete list of such physiological markers with rationale for each marker.
Respiratory distress analyzer 203 can represent an example of respiratory distress analyzer 103 and can analyze the patient condition parameters generated by signal processing circuit 202 and determine the state of the respiratory distress based on an outcome of the analysis. Respiratory distress analyzer 203 can include parameter inputs 204, a parameter analysis circuit 205, a storage device 214, and a notification circuit 215. Parameter inputs 204 can include a physiological marker input 206 and an other parameter input 207. Physiological marker input 206 can receive one or more physiological marker parameters generated by signal processing circuit 202, such as one or more parameters each indicative or being a measure of one or more physiological markers listed above (i-xix) or in Table 1. Other parameter input 107 can receive one or more other parameters that can be used in the determination of the state of the respiratory distress, including information entered by the patient and/or the user. In this document, a “user” can include a physician, other medical professional, or caregiver who attends the patient including monitoring and/or treating the patient using the present system. In some example, the “user” can also include the patient, such as when the patient is allowed to adjust certain operations of the system.
Parameter analysis circuit 205 can represent an example of parameter analysis circuit 105 and can determine the state of the respiratory distress based on the patient condition parameters received by parameter inputs 204. In one embodiment, parameter analysis circuit 205 determines a patient condition metric being a linear or nonlinear combination of the patient condition parameters, and produces one or more respiratory distress indicators indicating the state of the respiratory distress based on the patient condition metric. The patient condition parameters includes at least the one or more physiological marker parameters. Storage device 214 can store the state of the respiratory distress determined by parameter analysis circuit 205 over time. In various embodiments, parameter analysis circuit 205 can produce and analyze a trend of the state of the respiratory distress using the stored states. The trend allows respiratory distress analyzer 203 to identify changes in the patient's condition including changes in the state of the respiratory distress.
Notification circuit 215 can present the one or more respiratory distress indicators produced by parameter analysis circuit 205 to the patient and/or the user (e.g., through a user interface of a system illustrated in one of
Signal processing controller 213 can receive a processing control signal and adjust the processing of the patient condition signals based on the processing control signal. The processing control signal can include a signal indicative of a physical state of the patient, such as a signal indicating an activity level of the patient (e.g., sensed from the patient using an activity sensor) or a signal indicating whether the patient is sleeping (e.g., sensed from the patient using a sleep sensor). For example, the activity or sleep sensor may trigger sampling for heart rate, respiration rate, and lung sounds and processing of these signals only when the patient is sleeping or at rest. In various embodiments, signal processing controller 213 can adjust a sampling rate of signal processing circuit 202 based on the processing control signal and/or activate or deactivate signal processing circuit 202 based on the processing control signal. In various embodiments, signal processing controller 213 can also activate or deactivate other portions of respiratory distress monitoring circuit 200 and/or other portions of the present system (e.g., monitoring devices acquiring the patient condition signals) based on the processing control signal.
In one embodiment, monitoring device(s) 321, respiratory distress monitoring circuit 300, control circuit 322, and therapy device 323 are integrated into a single medical device. In other embodiments, monitoring device (s) 321, respiratory distress monitoring circuit 300, control circuit 322, and therapy device 323 can be implemented as two or more medical devices communicatively coupled to each other to form system 320. These two or more devices can be any combination of implantable, wearable, handheld, and/or remote devices.
In various embodiments, system 320 can include an implantable medical device that includes an implantable drug pump and/or a neuromodulation device (e.g., for delivering vagus nerve stimulation, pulmonary vagal fiber block therapy, and/or superior laryngeal nerve block therapy) to be used as therapy device 323. In various embodiments, such as when the patient is not connected to a therapy device, system 320 can send alerts or notifications to the patient and/or the user when the condition including the state of the respiratory distress is worsening and/or when medical intervention becomes necessary or recommendable. System 320 can detect and/or predict an exacerbation of the respiratory distress based on early or late stage of worsening symptoms and slow or rapid onset. For example, system 320 can send early stage warnings to the patient only and late stage warnings to the user in addition to the patient. In another example, system 320 can notify the patient in a slow onset for the patient to take action but notify the user in addition to the patient in a rapid onset. In various embodiments, system 320 can be used in combination with a medical condition management plan for the patient to follow, for example, by notifying the patient of the state and/or risk category of the respiratory distress such that the patient can adjust medication and/or daily activities accordingly.
In various embodiments, signal inputs 101 or 201 can receive environmental information related to the state of the respiratory distress, and parameter analysis circuit 105 or 205 can determine the state of the respiratory distress based on one or more physiological marker parameters and the received environmental information. Examples of the environmental information include time of day, time of year, GPS location, pollen levels, pollution levels, humidity levels, web information on local news, hospital admissions, and/or information on disease epidemic (e.g., flu or cold). The environmental information can be sensed using one or more sensors of monitoring device(s) 321 and/or provided by external sources.
In various embodiments, signal inputs 101 or 201 can receive user-input data related to the state of the respiratory distress. The user-input data can be entered by the patient and/or the user. Parameter analysis circuit 105 or 205 can determine the state of the respiratory distress based on the one or more physiological marker parameters and one or more of the received environmental information and the user-input data. Examples of the user data include a log of the patient's actual asthma attacks and/or COPD exacerbations, pharmaceutical use information, and/or allergies. In various embodiments, notification circuit 215 can provide the patient with custom recommendations based upon the user-input data.
In various embodiments, circuits of system 320, including its various embodiments discussed in this document, may be implemented using a combination of hardware and software. For example, the circuits may be implemented using an application-specific circuit constructed to perform one or more particular functions or a general-purpose circuit programmed to perform such function(s). Such a general-purpose circuit includes, but is not limited to, a microprocessor or a portion thereof, a microcontroller or portions thereof, and a programmable logic circuit or a portion thereof.
At 431, patient condition parameters are received and analyzed. The patient condition parameters can include one or more physiological marker parameters each indicative or being a measure of one or more physiological markers of the respiratory distress, such as those listed above (i-xix) or in Table 1. In some embodiments, the patient condition parameters can also include other parameters useable in determining the state of the respiratory distress, such as inputs from the patient and/or the user.
At 432, the state of the respiratory distress is determined based on an outcome of the analysis of the patient condition parameters. In one embodiment, a patient condition matrix is produced as a liner or nonlinear function of the patient condition parameters, and one or more indicators of the state of the respiratory distress are produced based on the patient condition metric.
If the state of the respiratory distress (e.g., a quantitative measure of the state) does not exceed a threshold at 433, method 430 continues from 431 again. If the state of the respiratory distress exceeds the threshold at 433, an alert is produced to notify the patient and/or the user, and/or one or more therapies treating the respiratory distress are delivered, at 434. Method 430 can continue from 431 again to monitor the state of the respiratory distress including the effect of the delivery of the one or more therapies and/or other medical intervention resulting from the alert.
System 320 can be implemented as a non-invasive, minimally invasive, partially implantable, or fully implantable system. When system 320 is a non-invasive system, one or more monitoring devices 321 include one or more non-invasive monitoring devices. In various embodiments, the one or more non-invasive monitoring devices can include one or more passive monitors, one or more wearable devices, one or more mobile cellular devices, one or more adhesive patches, and/or one or more any other forms of non-invasive monitoring devices suitable for acquiring the needed patient condition signals.
A passive monitor (also known as in-home patient monitor, bedside monitor, remote patient monitor, passive patient monitor, passive in-home monitor, passive bedside monitor, etc.) can identify the patient and sense one or more signals from the identified patient. In various embodiments, a passive monitor can use radio or microwave signals or cameras (visible or infrared) to identify individuals and detect signals. Radio or microwave signals can be used in this manner due to differences in wave reflection time back to the emitter, allowing for respiratory rate, heart rate, and movement to be detected. Cameras can be used based on minute color changes in the skin which occurs due to blood flow. Examples of physiological markers of the respiratory distress that can be sensed using a passive monitor include respiration rate, heart rate and HRV (including frequency and time domain measures), RSA (using respiratory and cardiac signals to derive RSA metrics from the expiratory and inspiratory periods of physiological signals, for example, acquired using two different filters to derive a respiratory rate signal and a heart rate signal, or using two passive monitors), activity, movement to capture activity levels and sleep quality metrics (sleep disturbances will appear as high-amplitude spikes in the data stream), and/or blood pressure (e.g., as indicated by pulse transit time measure captured by a bedside camera). A passive monitor can include a microphone to detect respiratory or lung sounds, coughing, and/or vocal expression. A passive monitor can include an ultrasound transmitter and receiver to detect patient movement and/or patient respiration.
A wearable monitor (also known as wearable, healthcare wearable, wearable sensor, etc.) can be worn by the patient and sense one or more signals from the patient. Examples of wearable monitors can include wrist-worns, rings, necklaces, anklets, and sensors embedded in clothing (chest patch for example). Examples of physiological markers of the respiratory distress that can be sensed using a wearable monitor include respiration rate (e.g., measured with accelerometers, gyroscopes, photoplethysmography (PPG) sensors, and/or impedance sensors), heart rate and heart rate variability (including frequency and time domain measures, e.g., measured via biopotential, bioimpedance, and/or PPG sensors), galvanic skin response (including time and frequency domain measures), blood pressure (including measurements such as systolic and diastolic blood pressure, pulse transit time, wave amplitude, and/or volume, BRS (captured by blood pressure and heart rate signals paired with one or more of activity, posture, and/or respiration signal), chemical marker (e.g. measured by sweat analysis), activity levels, sleep quality, vocal expression analysis, lung sounds, coughing, wheezing, and or external factors including location tracking, ambient temperature, and/or ambient humidity.
A mobile cellular device can be worn or carried by the patient or placed near the patient and sense one or more signals from the patient. An example of the mobile cellular device includes a smartphone with a patient monitoring application installed. Mobile cellular devices that allow for intermittent sensing of the patient condition signals include, for example: microphone for vocal expression analysis, accelerometer for activity tracking, global positioning system (GPS) for location tracking and associated external factors including temperature, ambient humidity, and/or allergen levels, and/or sensors coupled to mobile devices such as ECG sensors for recording heart rate, HRV (time and frequency domain measures), respiration rate, and RSA. Mobile cellular devices can also be used for continuous sensing of the patient condition signals while the patient is sleeping if the mobile devices are placed on mattress while sleeping. Examples of the patient condition parameters generated from signals continuously sensed include heart rate and HRV (time and frequency domain measures), respiration rate, RSA, and sleep quality parameters.
An adhesive patch including one or more sensors can be attached to the patient and sense one or more signals from the patient. Examples of physiological markers of the respiratory distress that can be sensed using an adhesive patch include ECG, heart sounds, HRV, respiration rate, RSA, lung sounds, and/or electromyogram (EMG) for neural respiratory drive. An adhesive patch can also be made capable of communicating with the user and/or insurance company to indicate when it is being worn by the patient to ensure compliance of treatment instructions and/or requirements.
In various embodiments, monitoring device(s) 321 can include one or more minimally invasive monitoring devices. For example, monitoring device(s) 321 can include sensors integrated with minimally invasive or borderline invasive devices such as diabetes monitor, microneedles, contact lens, tattoo, inhalable sensors, ingestible sensors, artificial limbs, and/or sensor placed in the nostril or sinus. In various embodiments, monitoring device(s) 321 can include one or more monitoring devices each integrated with one or more therapy devices such as nebulizer, respirator, continuous positive airway pressure (CPAP) machine, and/or chest compression devices. In various embodiments, non-invasive and/or minimally invasive monitoring devices, when used individually or in combination, can provide a system for the patients to track symptoms objectively over time, to identify when the patient's condition is deteriorating, and to provide information to the patient and/or the user when appropriate. These monitoring devices can also provide inputs to a closed-loop therapy system.
In various embodiments, the state of the respiratory distress can be monitored using one or more respiration-mediated physiological parameters, such as one or more measures of respiratory sinus arrhythmia (RSA), that are indicative of the patient's autonomic balance. The state of the respiratory distress can be measured by a degree of autonomic imbalance.
Respiratory distress monitoring circuit 100, 200, or 300 can be configured to monitor the state of the respiratory distress using one or more respiration-mediated physiological parameters, such as one or more measures of RSA. Referring back to
Referring back to
Parameter analysis circuit 205 can be configured to determine the state of the respiratory distress based on at least the one or more respiration-mediated physiological parameters. In one embodiment, parameter analysis circuit 205 can be configured to produce a respiration-mediated signal metric including a linear or nonlinear combination of the respiration-mediated physiological parameters and to produce the one or more respiratory distress indicators indicating the state of the respiratory distress based on the respiration-mediated signal metric. In various embodiments, respiratory distress monitoring circuit 300 can be configured to monitor the state of the respiratory distress using the one or more respiration-mediated physiological parameters in combination with any one or more other physiological marker parameters, and/or other parameters related to the respiratory disorder, that are discussed in this document.
Referring back to
At 1071, patient condition signals are received. The patient condition signals include a respiratory signal indicative of inspiration and expiration times and a cardiac signal indicative of R-R interval (i.e., as referred to as cardiac cycle length or ventricular rate interval, measure as the time interval between consecutive R-waves). At 1072, the patient condition metric (e.g., the RSA metric) is determined using the respiratory and cardiac signals. At 1073, the state of the respiratory distress is determined based the patient condition metric such as the RSA metric. If the state of the respiratory distress (e.g., a quantitative measure of the state) does not exceed a threshold at 1074, method 1070 continues from 1071 again. If the state of the respiratory distress exceeds the threshold at 1074, an alert is produced to notify the patient and/or the user, and/or one or more therapies treating the respiratory distress are delivered, at 1075. Method 1070 can continue from 1071 again to monitor the state of the respiratory distress including the effect of the delivery of the one or more therapies and/or other medical intervention resulting from the alert.
In various embodiments, the state of the respiratory distress can be monitored using one or more respiration-mediated physiological parameters, such as one or more measures of baroreflex sensitivity (BRS) that are indicative of the patient's autonomic balance. The state of the respiratory distress can be measured by a degree of autonomic imbalance.
Respiratory distress monitoring circuit 100, 200, or 300 can be configured to monitor the state of the respiratory distress using one or more BRS parameters being one or more measures of BRS. Referring back to
Referring back to
The one or more physical state parameters can include, but are not limited to, one or more of the following parameters:
Parameter analysis circuit 205 can be configured to determine the state of the respiratory distress based on at least the one or more BRS parameters and the one or more physical state parameters. In one embodiment, parameter analysis circuit 205 can be configured to produce a BRS metric including a linear or nonlinear combination of the one or more BRS parameters as stratified by the one or more physical state parameters and to produce the one or more respiratory distress indicators indicating the state of the respiratory distress based on the BRS metric. In various embodiments, respiratory distress monitoring circuit 300 can be configured to monitor the state of the respiratory distress using the one or more BRS parameters and the one or more physical state parameters in combination with any one or more other physiological marker parameters, and/or other parameters related to the respiratory disorder, that are discussed in this document.
Referring back to
At 1481, patient condition signals are received. The patient condition signals include a respiratory signal indicative of inspiration and expiration times, a cardiac signal indicative of R-R interval, and a blood pressure signal indicative systolic blood pressure. At 1482, the BRS metric is determined using the respiratory, cardiac, and blood pressure signals. At 1483, the state of the respiratory distress is determined based the BRS metric. If the state of the respiratory distress (e.g., a quantitative measure of the state) does not exceed a threshold at 1484, method 1480 continues from 1481 again. If the state of the respiratory distress exceeds the threshold at 1484, an alert is produced to notify the patient and/or the user, and/or one or more therapies treating the respiratory distress are delivered, at 1485. Method 1480 can continue from 1481 again to monitor the state of the respiratory distress including the effect of the delivery of the one or more therapies and/or other medical intervention resulting from the alert.
It is to be understood that the above detailed description is intended to be illustrative, and not restrictive. Other embodiments will be apparent to those of skill in the art upon reading and understanding the above description. The scope of the invention should, therefore, be determined with reference to the appended claims, along with the full scope of equivalents to which such claims are entitled.
This application claims the benefit of priority under 35 U.S.C. § 119(e) of U.S. Provisional Patent Application Ser. No. 62/595,174, filed on Dec. 6, 2017, which is herein incorporated by reference in its entirety. This application is related to commonly assigned U.S. Provisional Patent Application Ser. No. 62/595,166, entitled “NON-INVASIVE SYSTEM FOR MONITORING AND TREATING RESPIRATORY DISTRESS”, filed on Dec. 6, 2017, which is incorporated by reference in their entirety.
| Number | Name | Date | Kind |
|---|---|---|---|
| 6015388 | Sackner et al. | Jan 2000 | A |
| 6129675 | Jay | Oct 2000 | A |
| 7077810 | Lange et al. | Jul 2006 | B2 |
| 7160252 | Cho et al. | Jan 2007 | B2 |
| 7186220 | Stahmann et al. | Mar 2007 | B2 |
| 7575553 | Stahmann et al. | Aug 2009 | B2 |
| 7678061 | Lee et al. | Mar 2010 | B2 |
| 7690378 | Turcott | Apr 2010 | B1 |
| 8065001 | Nabutovsky et al. | Nov 2011 | B1 |
| 8323204 | Stahmann et al. | Dec 2012 | B2 |
| 8403861 | Williams et al. | Mar 2013 | B2 |
| 8403865 | Halperin | Mar 2013 | B2 |
| 9066659 | Thakur et al. | Jun 2015 | B2 |
| 20040116784 | Gavish | Jun 2004 | A1 |
| 20040249416 | Yun | Dec 2004 | A1 |
| 20050036943 | Broughton | Feb 2005 | A1 |
| 20050240241 | Yun | Oct 2005 | A1 |
| 20060100666 | Wilkinson et al. | May 2006 | A1 |
| 20070048180 | Gabriel et al. | Mar 2007 | A1 |
| 20080269625 | Halperin | Oct 2008 | A1 |
| 20100275921 | Schindhelm et al. | Nov 2010 | A1 |
| 20120116241 | Shieh et al. | May 2012 | A1 |
| 20120303079 | Mahajan | Nov 2012 | A1 |
| 20130018595 | Atakhorrami et al. | Jan 2013 | A1 |
| 20130310699 | Hart et al. | Nov 2013 | A1 |
| 20140277278 | Keel | Sep 2014 | A1 |
| 20150148699 | Wariar et al. | May 2015 | A1 |
| 20160224750 | Kethman et al. | Aug 2016 | A1 |
| 20170161453 | Stahmann et al. | Jun 2017 | A1 |
| 20170347968 | Maile et al. | Dec 2017 | A1 |
| 20170347969 | Thakur et al. | Dec 2017 | A1 |
| 20180055564 | Clark et al. | Mar 2018 | A1 |
| 20180056074 | Clark et al. | Mar 2018 | A1 |
| 20190167209 | Annoni et al. | Jun 2019 | A1 |
| Number | Date | Country |
|---|---|---|
| 3171768 | Sep 2020 | EP |
| WO-WO2016019250 | Feb 2016 | WO |
| Entry |
|---|
| “Asthma”, CDC website for Asthma: https://www.cdc.gov/nchs/fastats/asthma.htm, Mar. 31, 2017, (3 pps.). |
| “Asthma: Could your childhood asthma recur?”, https://www.healthxchange.sg/asthma/essential-guide-asthma/childhood-asthma-recur, Nov. 6, 2018, 5 pgs. |
| “Chronic Obstructive Pulmonary Disease (COPD) Includes: Chronic Bronchitis and Emphysema”, CDC website for COPD: https://www.cdc.gov/nchs/fastats/copd.htm, Nov. 6, 2018, 3 pps. |
| Devi, TH Pricila, et al., “A study of the sympathetic nervous system in bronchial asthma”, Journal of Medical Society / Sep.-Dec. 2012 / vol. 26 | Issue 3. |
| Dinakar, Chitra, “Management of acute loss of asthma control in the yellow zone: a practice parameter”, Ann Allergy Asthma Immunol 113 (2014) 143-159. |
| Emin, Ozkaya, et al., “Autonomic dysfunction and clinical severity of disease in children with allergic rhinitis”, International Journal of Pediatric Otorhinolaryngology 76 (2012) 1196-1200. |
| Gouveia, S., et al., “Assessing Baroreflex Sensitivity in the Sequences Technique: Local versus Global Approach”, Computers in Cardiology 2005;32:279-282. |
| Hayano, Junichiro, et al., “Hypothesis: respiratory sinus arrhythmia is an intrinsic resting function of cardiopulmonary system”, Cardiovascular Research 58 (2003) 1-9. |
| Heffernan, K.S., et al., “Arterial Stiffness and Baroreflex Sensitivity Following Bouts of Aerobic and Resistance Exercise”, Int J Sports Med 2007; 28: 197-203. |
| Jartti, Tuomas T., et al., “Altered cardiovascular autonomic regulation after salmeterol treatment in asthmatic children”, Clinical Physiology 18, 4, 345-353 © 1998 Blackwell Science Ltd. |
| Jartti, Tuomas, et al., “The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis”, Br J Clin Pharmacol 1997; 43: 421-428. |
| Kallenbach, J.M, et al., “Reflex Heart Rate Control in Asthma* Evidence of Parasympathetic Overactivity”, Chest 1985;87;644-648. |
| Lewis, M.J., et al., “Autonomic nervous system control of the cardiovascular and respiratory systems in asthma”, Respiratory Medicine (2006) 100, 1688-1705. |
| Ogoh, Shigehiko, et al., “Autonomic nervous system influence on arterial baroreflex control of heart rate during exercise in humans”, J Physiol 566.2 (2005) pp. 599-611. |
| Papiris, Spyros, et al., “Clinical review: Severe asthma”, Critical Care, Feb. 2002, 6:1, 30-44. |
| Parlow, Joel, et al., “Comparison With Drug-Induced Responses”, Hypertension May 1995, vol. 25, Issue 5, https://www.ahajournals.org/doi/full/10.1161/01.HYP.25.5.1058, 17 pgs. |
| Partridge, Martyn R., et al., “Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study”, BMC Pulmonary Medicine 2006, 6:13, 9 pgs. |
| Patakas, D., et al., “Reduced baroreceptor sensitivity in patients with chronic obstructive pulmonary disease”, thorax 1982 ;37 :292-295. |
| Reis, Michel Silva, et al., “Deep Breathing Heart Rate Variability is Associated With Respiratory Muscle Weakness in Patients With Chronic Obstructive Pulmonary Disease”, Clinics 2010;65(4):369-75. |
| Seemungal, Terence, et al., “Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease”, Am J Respir Crit Care Med vol. 164. pp. 1618-1623, 2001. |
| Sherwood, Greg, et al., “Systems and Methods for Assessing the Health Status of a Patient”, U.S. Appl. No. 15/982,506, filed May 17, 2018. |
| Swenne, C. A., “Baroreflex sensitivity: mechanisms and measurement”, Neth Heart J 21, (2013), 58-60. |
| Tattersfield, Anne E., et al., “Exacerbations of Asthma, A Descriptive Study of 425 Severe Exacerbations”, Am J Respir Crit Care Med 1999;160:594-599. |
| Van Den Berge, Maarten, et al., “Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease”, Respiratory Research 2012, 13:44, http://respiratory-research.com/content/13/1/44, 9 pgs. |
| Van Gestel, Arnoldus Jr, et al., “Autonomic dysfunction in patients with chronic obstructive pulmonary disease (COPD)”, J Thorac Dis 2010; 2: 215-222. |
| Volterrani, Maurizio, et al., “Decreased Heart Rate Variability in Patients With Chronic Obstructive Pulmonary Disease*”, Chest /106 / 5 / Nov. 1994, 1433-1437. |
| “U.S. Appl. No. 16/184,020, Advisory Action dated Nov. 3, 2021”, 3 pgs. |
| “U.S. Appl. No. 16/184,020, Final Office Action dated Sep. 9, 2021”, 15 pgs. |
| “U.S. Appl. No. 16/184,020, Non Final Office Action dated Mar. 16, 2021”, 14 pgs. |
| “U.S. Appl. No. 16/184,020, Non Final Office Action dated May 11, 2022”, 14 pgs. |
| “U.S. Appl. No. 16/184,020, Response filed Jun. 8, 2021 to Non Final Office Action dated Mar. 16, 2021”, 10 pgs. |
| “U.S. Appl. No. 16/184,020, Response filed Oct. 25, 2021 to Final Office Action dated Sep. 9, 2021”, 11 pgs. |
| “U.S. Appl. No. 16/184,020, Response filed Dec. 22, 2020 to Restriction Requirement dated Oct. 30, 2020”, 7 pgs. |
| “U.S. Appl. No. 16/184,020, Restriction Requirement dated Oct. 30, 2020”, 6 pgs. |
| Narkiewicz, K, et al., “Baroreflex control of sympathetic nerve activity and heart rate in obstructive sleep apnea”, Hypertension. 32(6), (Dec. 1998), 1039-43. |
| “U.S. Appl. No. 16/184,020, Response filed Aug. 10, 2022 to Non Final Office Action dated May 11, 2022”, 11 pgs. |
| Number | Date | Country | |
|---|---|---|---|
| 20190167176 A1 | Jun 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62595174 | Dec 2017 | US |
